Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Recovery article

Tesamorelin

Tesamorelin Buy 3 for $45.00 each and save 10% Buy 5 for $40.00 each and save 20% Buy 10 for $35.00 each and save 30% Buy this product and Earn 50.00 Reward Points click here to login FREE Shipping for orders over $200 For this product you will need: BACTERIOS

By Recovery & Performance Peptides Editorial Team

Tesamorelin

Buy 3 for $45.00 each and save 10%

Buy 5 for $40.00 each and save 20%

Buy 10 for $35.00 each and save 30%

Buy this product and Earn 50.00 Reward Points click here to login

FREE Shipping for orders over $200

For this product you will need: BACTERIOSTATIC WATER For reconstitution.

Sarms

Stacks

Research Liquids

Albuterol 5MG/ML | 30ML with dropper

Anastrozole 1.5MG/ML | 30ML with dropper

Clomiphene 50MG/ML | 30ML with dropper

Finasteride 5MG/ML | 30ML with dropper

Letrozole 3.5 MG/ML | 30ML with dropper

LiquiCia 30MG/ML | 30ML with dropper

LiquiCia T50 50MG/ML | 30ML with dropper

LiquiClen 200MCG/ML | 30ML with dropper

Liquistane / Exemestane 25MG/ML | 30ML with dropper

LiquiTamo 20MG/ML | 30ML with dropper

LiquiVia 25MG/ML | 30 ML with dropper

T3 LIOTHYRONINE 200MCG/ML | 30ML with dropper

Toremifene Citrate 60MG/ML | 30ML with dropper

Yohimbine HCL 10MG/ML | 30ML with dropper

Research Peptides

Aicar 50MG

BPC-157 + TB-500 Blend 2mg ea/ 4MG

BPC-157 5MG

CJC-1295 + DAC 2MG

CJC-1295 | No DAC 2MG

Epithalon 10MG

Frag Premium 176-191 5MG

GHK-CU Copper Peptide 50MG

GHRP-2 5MG

GHRP-6 5MG

Hexarelin 5MG

IGF-1 DES 1MG

IGF-1 LR3 1MG

Ipamorelin 5MG

Melanotan 2 10MG

NAD+ 500MG

PT-141 / Bremelanotide 10MG

GLP-1/GIP/GCG (RT)

Selank 5MG

GLP1 (SM)

Sermorelin 5MG

TB-500 5MG

Tesamorelin

GIP/GLP-1 (TZ)

PDE5 Inhibitors

GLP-1

Diluents

Bacteriostatic Water 10ML

What Is Tesamorelin?

Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). It binds with receptors in the pituitary gland and stimulates the release of growth hormone. It is composed of 44 amino acids and a trans-3-hexenoic acid group, which makes it more stable and extends its half-life as compared to endogenous GHRH.

It was first developed by a Canadian company named Theratechnologies Inc. for the treatment of lipodystrophy. FDA approved it for the treatment of HIV-associated lipodystrophy in 2010. Currently, it has been researched for its effect on the cardiovascular system and peripheral nerve damage. On our website, tesamorelin for sale is limited to research and educational purposes.

Structure Of Tesamorelin

From Pubchem

Molecular Formula: C216H360N72O63S Molecular Weight: 5006 g/molSequence: YADAXFXNSYRKVLGQLSARKLLQDXMSRQQGQSNQRGARARL CAS number: 218949-48-5 PubChem CID: 56928011

Tesamorelin Uses In Research

1. Tesamorelin and HIV-associated Lipodystrophy

Tesamorelin has already been approved by the FDA for the treatment of HIV-associated lipodystrophy. The antiretroviral therapy and HIV infection itself cause significant changes in body composition, including fat distribution. Lipodystrophy is characterized by excessive visceral adipose tissue in the abdomen, trunk and breast. It also causes loss of visceral adipose tissue in the face, arms, legs and buttocks.

Further, the accumulation of visceral adipose tissue is linked with insulin resistance and increased risk of heart disease and diabetes mellitus [1]. FDA-approved human recombinant growth hormone for the management of lipodystrophy. But it requires large doses that can cause further complications, including peripheral edema and carpal tunnel syndrome. On the other hand, tesamorelin is a safe and effective option for managing fat accumulation.

In a randomized controlled phase three trial, HIV patients with central obesity received either tesamorelin or a placebo for 26 weeks. After that, patients on tesamorelin were randomly switched to tesamorelin or placebo and the control group was switched to tesamorelin. The results found that a change in visceral adipose tissue was sustained during the course of the research. However, researchers observed reaccumulation of fat when tesamorelin was discontinued [2].

2. Tesamorelin in cardiovascular diseases

People with HIV are more likely to develop cardiovascular disease due to increased belly fat and the side effects of antiretroviral medications. Cardiovascular disease prevention is the most important medical intervention for HIV-positive patients after antiretroviral therapy.

Tesamorelin has been demonstrated to lower triglyceride, total, and non-HDL-C levels in HIV-positive patients in addition to reducing lipodystrophy. It was discovered that tesamorelin drastically decreased subcutaneous adipose tissue (body fat) by 15%[3].

3. Tesamorelin and Dementia

According to studies, GHRH analogues like tesamorelin may help patients with moderate cognitive impairment by enhancing their cognitive function.

Tesamorelin might boost levels of several neurotransmitters in the brain that are linked to the prevention and treatment of cognitive decline by increasing gamma-aminobutyric acid (GABA), [4].

4. Tesamorelin and Peripheral Nerve Damage

Peripheral nerve damage can occur because of multiple reasons, including diabetes, injury or surgical interventions. It can affect a person's ability to control movements and result in loss of sensory function. Nerve cells are difficult to regenerate, so there are not many therapies.

Research shows that growth hormone-based therapies might have the potential to speed up the regeneration of axons [5]. Axonal regeneration is important as it helps neurons to reach distal targets. Tesamorelin might help in restoring nerve damage. Clinical trials are ongoing to assess its effectiveness for peripheral nerve damage.

5. Current status of Tesamorelin

Tesamorelin has already been approved for the treatment of HIV-associated dystrophy. It is currently being examined for its potential to lessen cardiovascular disease in HIV patients, enhance the recovery of injured peripheral nerves, and decrease the course of dementia. Many other clinical trials are already in progress.

Tesamorelin has very few adverse effects, limited oral bioavailability, and great subcutaneous absorption. At Element Sarms, tesamorelin purchase is available for research purposes only. Only buy Tesamorelin if you are an authorized researcher.

Referenced Citations

Bedimo, R., Growth hormone and tesamorelin in the management of HIV-associated lipodystrophy. HIV AIDS (Auckl), 2011. 3: p. 69-79.

Falutz, J., et al., Long-term safety and effects of tesamorelin, a growth hormone-releasing factor analogue, in HIV patients with abdominal fat accumulation. Aids, 2008. 22(14): p. 1719-28.

Stanley, T.L., et al., Reduction in visceral adiposity is associated with an improved metabolic profile in HIV-infected patients receiving tesamorelin. Clinical infectious diseases, 2012. 54(11): p. 1642-1651.

Friedman, S.D., et al., Growth Hormone–Releasing Hormone effects on brain γ-Aminobutyric acid levels in mild cognitive impairment and healthy aging. JAMA neurology, 2013. 70(7): p. 883-890.

Tuffaha, S.H., et al., Therapeutic augmentation of the growth hormone axis to improve outcomes following peripheral nerve injury. Expert Opinion on Therapeutic Targets, 2016. 20(10): p. 1259-1265.

Certificate of Analysis (COA)

High Performance Liquid Chromatography (HPLC)

Mass Spectrometry (MS)

CONNECTED / MODULES

Post-session references

Selected from shared article topics. Source links are retained where available.

01

Handling & safety lane

Source-derived education, not individual medical guidance or an instruction to dose.

DOSAGE SOURCE

Dosages

Tesamorelin is typically administered to treat HIV-associated lipodystrophy in adults. The standard dosage involves a daily subcutaneous injection of 2 mg, delivered using a reconstituted solution from a lyophilized powder. Patients are instructed to inject the medication into the abdominal area, rotating injection sites to minimize skin irritation. Treatment duration varies, often continuing for several months to achieve and maintain reductions in visceral fat, as determined by a physician.
02

Question drills

Open a question for its connected answer.

01Where to find tesamorelin+

Clinics have been prescribing peptides to private clients for years, and telehealth is only just catching up. Even among the reputable telehealth providers that are riding the peptide wave, the selection is usually limited to GLP-1 receptor agonists like Ozempic, Wegovy, and Mounjaro. Tesamorelin, however, isn’t a GLP-1 RA and currently isn’t offered by many leading telehealth platforms such as Hims, Hers, Eden, Henry Meds, or Strut. Right now, the best way to get a tesamorelin prescription is through a local medical provider. Because the telehealth space is playing catch-up, less-reputable outfits have seen an opportunity to capitalize on the growing public interest in peptide therapy. That’s why you can still find a few online purveyors that carry tesamorelin, and it’s tough to say whether or not a given one is trustworthy. Often, you’ll find that they sell research-grade tesamorelin, which is intended only for laboratory use. If you were to inject research-grade tesamorelin into your body, you run the risk of introducing contaminants that could cause serious harm. Legitimate online peptide purveyors will deal exclusively in products labeled “pharmaceutical-grade” or “GMP API,” which indicates FDA approval for human use. However, among the few online providers that offer tesamorelin, none of them appear to be well-represented on the major consumer watchdog sites. They tend to have only a handful of reviews, and that’s hardly enough to feel confident about the honesty of their labeling or the quality of their products. Again, we’re not saying one or another operation is not legit, only that we can’t confidently make an accurate assessment at this time.

SOURCE / www.innerbody.com ↗
03

Evidence cooldown

Research context and source excerpts for a slower second read.

RESEARCH

The Tesamorelin peptide is a synthetic analog and hormone releasing factor analogue of growth hormone–releasing hormone (GHRH) that has been widely studied in laboratory and clinical research settings for its role in stimulating endogenous growth hormone secretion. Tesamorelin (pronounced “moe rel”) is a synthetic growth hormone-releasing hormone (GHRH) analogue that has been helping patients manage a challenging metabolic condition for over a decade.

The approved indication for Tesamorelin is the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with antiviral therapy-related lipodystrophy. It was approved by the FDA in 2010 and was produced and developed by Theratechnologies, Inc. of Canada. Understanding how this treatment works, its benefits, and its safety considerations can help patients make informed decisions alongside their healthcare team. Tesamorelin is used in the context of acquired immune deficiency syndromes, and the recommended dose is 2 mg daily by subcutaneous injection.

Continue reading

Related articles

Tesamorelin

Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH), designed to stimulate the release of endogenous growth hormone (GH) from the pituitary gland. Developed by Theratechnologies Inc., a …

Read article